Data Collection Improves Patient Outcomes in Hospice, Palliative Care

Share this content:

the Cancer Therapy Advisor take:

Routine data collection and feedback at point-of-care improves most patient outcomes in hospice and palliative care, according to a recent study published in Supportive Care in Cancer.

David Currow, MD, and fellow researchers at Flinders University in Adelaide, Australia, examined data from 19,747 patients taken from the Australian Palliative Care Outcomes Collaboration in order to measure outcomes in the last three years. Point-of-care data points were set from July to December of 2008, subsequently compared to baseline data in six different six-month cycles for all submitted data.

The researchers found significant improvements across all domains of symptom control, family care, as well as psychological and spiritual care. However, they found no improvement in pain.

Additionally, they noted that interquartile ranges had decreased, which was indicative of better and more consistent patient outcomes that were being achieved with more data collection.

“These are the first national hospice/palliative care symptom control performance data to demonstrate improvements in clinical outcomes at a service level as a result of routine data collection and systematic feedback,” the authors concluded.

End-of-Life Palliative Chemotherapy: More Harm Than Good?
Routine data collection and feedback at point-of-care improves most patient outcomes in hospice and palliative care.
These are the first national hospice/palliative care symptom control performance data to demonstrate improvements in clinical outcomes at a service level as a result of routine data collection and systematic feedback.
READ FULL ARTICLE From Mdlinx

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters